| REVIEW ARTICLE |
|
| Year : 2011 | Volume
: 5
| Issue : 2 | Page : 128-133 |
|
|
Current role of dexmedetomidine in clinical anesthesia and intensive care
Manpreet Kaur1, PM Singh2
1 Department of Anaesthesia and Critical Care, All India Institute of Medical Sciences, J.P.N.A Trauma Centre, New Delhi, India
2 Department of Anaesthesia and Critical Care, All India Institute of Medical Sciences, New Delhi, India
Correspondence Address:
Manpreet Kaur
Department of Anaesthesia, All India Institute of Medical Sciences, J.P.N.A Trauma Centre, New Delhi - 110 029
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0259-1162.94750
|
|
|
Dexmedetomidine is a new generation highly selective α 2-adrenergic receptor (α 2-AR) agonist that is associated with sedative and analgesic sparing effects, reduced delirium and agitation, perioperative sympatholysis, cardiovascular stabilizing effects, and preservation of respiratory function. The aim of this review is to present the most recent topics regarding the advantages in using dexmedetomidine in clinical anesthesia and intensive care, while discussing the controversial issues of its harmful effects. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
